CD3-directed Antibody [EPC]

720 reported adverse events

Drugs of this class: TEPLIZUMAB-MZWV

These side effects are most commonly reported by patients taking drugs of the CD3-directed Antibody [EPC] class:

# Side effect Count
0 RASH 166
1 NAUSEA 139
2 PYREXIA 120
3 FATIGUE 119
4 VOMITING 92
5 HEADACHE 86
6 LYMPHOPENIA 62
7 LYMPHOCYTE COUNT DECREASED 55
8 CHILLS 51
9 RASH PRURITIC 44
See all common reactions for CD3-directed Antibody [EPC]

Drugs of the CD3-directed Antibody [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INSULIN THERAPY 1 0.0833
1 LEUKOCYTE VACUOLISATION 1 0.0625
2 BLOOD FIBRINOGEN ABNORMAL 1 0.0175
3 BASOPHILIA 1 0.0133
4 LYMPHOCYTE COUNT ABNORMAL 13 0.0115
5 YERSINIA INFECTION 1 0.0098
6 CATHETER SITE DISCOLOURATION 1 0.0082
7 NONINFECTIVE SIALOADENITIS 1 0.0063
8 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 8 0.0061
9 POSTPRANDIAL HYPOGLYCAEMIA 1 0.0053
See all enriched reactions for CD3-directed Antibody [EPC]